Pfizer Leads the Dow Higher as Oil, Jobs Lift Optimism
Volatility for the markets continues as stock investors added to the Dow's gains from earlier in the week.
Why Hospira Shares Soared Today
Pfizer Inc has agreed to purchase Hospira in a deal worth as much as $17 billion, including debt.
Why Johnson & Johnson's Stock Could Crater in 2015
Johnson & Johnson is facing some serious threats to its top line this year. Here's what investors need to know going forward.